Dr. Kurr Advisory
Strategic Clarity. Scalable Models. Profitable Growth.
Fractional C-level leadership and transformation advisory for Pharma & Life Sciences - from a leader who built one of the industry’s leading service organizations from scratch.
Built From Experience, Not Theory
Most advisors consult. I’ve built and operated the organizations I now advise on. Every recommendation comes from having done it - at scale, under pressure, in regulated environments.
10x
Organization growth at Boehringer Ingelheim - built from zero to full global scale
20+
Years of corporate transformation across pharma, automotive, and manufacturing
#1
Content supply chain in the industry per external benchmarking studies
5
Major global organizations transformed - BI, Novartis, Roche, Daimler, Schott
Where I Can Help
Six areas where 20+ years of hands-on transformation experience translates directly into value for your organization.
Fractional C-Level Leadership
Part-time CCO, CTO, or COO for organizations that need senior executive bandwidth without the full-time commitment. Ideal for scale-ups, portfolio companies, and organizations in transition.
- Fractional Chief Commercial Officer (CCO)
- Fractional Chief Transformation Officer (CTO)
- Fractional Chief Operating Officer (COO)
- Interim leadership during executive transitions
- C-suite coaching and executive sparring
Global Operating Model Design
Designing and implementing scalable operating models that balance centralization with local agility - including shared services, offshoring, and nearshoring strategies.
- Insource vs. outsource strategy
- Off- and nearshoring center design
- Shared services center build-out
- Vendor and partner ecosystem optimization
- Stage-gate transition planning
AI & Digital Strategy for Regulated Industries
Practical AI adoption that works within pharma compliance frameworks. No hype - just AI that fits governed workflows, accelerates execution, and respects accountability.
- AI readiness assessment and roadmap
- Agentic AI strategy for commercial operations
- MLR workflow optimization with AI
- Content supply chain automation
- Human-in-the-loop governance design
Commercial & Medical Operations Transformation
Redesigning go-to-market and medical affairs operations for efficiency, scale, and omnichannel engagement - the same approach that built an industry-leading service organization.
- Go-to-market operating model redesign
- Content factory and creative services build
- Omnichannel engagement strategy
- Medical affairs services optimization
- Market access and value management
Strategic Partnerships & Alliances
Structuring, launching, and managing strategic cooperations - from vendor partnerships to industry alliances. Based on published research and 20+ years of partnership management.
- Strategic partner selection and due diligence
- Partnership governance design
- Vendor consolidation and optimization
- Joint venture and alliance structuring
- Partnership performance management
Organizational Design & People Strategy
Building high-performing global teams from the ground up. Designing organizations that attract talent, empower leaders, and scale without losing culture.
- Organization design and restructuring
- Global team build-out and scaling
- Talent strategy for transformation programs
- Change management and adoption
- Leadership development and team coaching
Who This Is For
Deep domain expertise across Pharma & Life Sciences - with cross-industry perspective from automotive, diagnostics, and manufacturing.
Pharma & Life Sciences
Pharma & Biotech
- Large pharma transformations
- Specialty pharma scale-up
- Emerging biotech commercialization
- Go-to-market redesign
MedTech & Diagnostics
- Commercial operations optimization
- Digital health strategy
- Device company scaling
- Market access and reimbursement
Life Sciences Services
- CRO / CDMO optimization
- Contract commercialization (CCO)
- Service delivery transformation
- Global capability build-out
HealthTech & Digital Health
- Enterprise AI adoption
- Platform go-to-market strategy
- Regulatory technology strategy
- Health data analytics operations
Cross-Industry
Automotive & Mobility
- Operating model redesign
- Supply chain cooperation management
- Shared services & GBS design
- Content & digital operations
Industrial Manufacturing
- Process-oriented reorganization
- Complexity management
- Industry 4.0 strategy
- Strategic alliance advisory
Consumer Goods (CPG)
- Content supply chain design
- Digital content factory setup
- Omnichannel content strategy
- Agency-to-in-house transition
Financial Services
- GBS design & optimization
- Operating model transformation
- Process reengineering for compliance
- Fintech partnership governance
Technology & SaaS
- Fractional COO/CCO for scale-ups
- Go-to-market operations design
- Partnership & alliance strategy
- Organizational design for scale
Energy & Chemicals
- Energy transition transformation
- Joint venture & alliance advisory
- Shared services optimization
- Change management at scale
Specialized Engagements
Investors & Venture Capital
- Commercial due diligence
- Portfolio company advisory
- Market access & pricing assessment
- Operating partner / venture partner
Boards & Governance
- Non-executive director roles
- Supervisory board service (DACH)
- Strategic governance advisory
- Pre-IPO board preparation
Executive Education & Speaking
- Conference keynote speeches
- Corporate executive workshops
- University & MBA guest lectures
- Panel moderation
Interim & Turnaround Management
- Post-merger integration
- Commercial organization turnaround
- Executive transition leadership
- Crisis management & stabilization
Expert Networks & Micro-Advisory
- GLG, AlphaSights, Guidepoint calls
- Investment research consultations
- Corporate strategy micro-advisory
- Rapid-turnaround industry briefings
Typical Scenarios
Situations where a fractional executive or transformation advisor delivers outsized value.
“We need to build a global services organization - but we’ve never done it.”
You need someone who has built one from scratch, scaled it 10x, and achieved full global coverage in 4 years. That’s what I did at Boehringer Ingelheim.
“Our content supply chain is broken - we’re slow, expensive, and inconsistent.”
Content operations at scale require the right mix of people, process, technology, and offshore leverage. I built what external benchmarks called the #1 content supply chain in pharma.
“We want to adopt AI - but we’re in a regulated industry and don’t know where to start.”
AI in pharma requires compliance-first thinking. I help organizations find the practical use cases that deliver value inside governed workflows - without the hype.
“We have a great strategy - but our operating model can’t execute it.”
Structure follows process follows strategy. If your operating model doesn’t fit your strategy, you’re burning budget. I redesign models that actually work.
“We’re a biotech scaling to commercial - we need C-level experience without a full-time hire.”
Fractional leadership gives you seasoned executive guidance 2-3 days per week - the strategic depth of a full-time hire at a fraction of the cost. Currently serving as Fractional CCO at Lemna Bio.
“Our board needs a pharma-experienced advisor for portfolio company oversight.”
As a Fellow at THENA Capital (UK MedTech investor), I provide strategic counsel to boards and investors evaluating or supporting pharma and MedTech companies.
Engagement Models
Flexible formats designed around your needs - not mine.
Fractional C-Level
Ongoing · 2-3 days/week
Embedded executive leadership on a part-time basis. Board-level presence, strategic ownership, and hands-on team guidance. Ideal for scale-ups and organizations in transition.
Transformation Sprint
3-6 months · Focused engagement
Intensive advisory for a specific challenge: operating model redesign, AI readiness, content factory build, or commercial transformation. Defined scope, clear deliverables.
Board & Strategic Advisory
Periodic · As needed
Strategic counsel for boards, investors, and executive teams. Portfolio company oversight, due diligence support, and transformation readiness assessment.
Active Mandates
Lemna Bio
Fractional CCO · Strategy & Partnerships
Computational drug design company in Lausanne developing complex mini-protein therapeutics. Leading commercial strategy and partnership development.
THENA Capital
Fellow · MedTech Investment
UK-based specialist MedTech investor focused on early-stage digital and device companies improving patient outcomes. Providing strategic advisory to the portfolio.
Dr. Kurr Advisory
Founder · Independent Advisory
Independent platform for fractional C-level and advisory mandates in Pharma & Life Sciences. Open for new engagements.
Frequently Asked Questions
Dr. Kurr Advisory offers fractional C-level leadership (CCO, CTO, COO), corporate transformation advisory, global operating model design, AI and digital strategy for regulated industries, commercial and medical operations transformation, and organizational design and scaling - all focused on Pharma & Life Sciences.
Dr. Kurr Advisory primarily serves Pharma & Biotech companies (large pharma, specialty pharma, emerging biotech), MedTech & Diagnostics organizations, Life Sciences Services companies (CROs, CDMOs, CCOs), and Healthcare Technology firms. Dr. Kurr has direct experience at Boehringer Ingelheim, Novartis, Roche Diagnostics, Daimler, and Schott.
Dr. Kurr Advisory offers three engagement models: Fractional C-Level mandates (ongoing part-time executive leadership, typically 2-3 days per week), Transformation Sprints (focused 3-6 month engagements for specific challenges like operating model design or AI readiness), and Board & Strategic Advisory (periodic strategic counsel for boards, investors, and executive teams).
Let’s Talk
Looking for fractional C-level support, transformation advisory, or strategic counsel? I’m always open to a conversation.